Systemic increase in type I interferon activity in Sjögren's syndrome: A putative role for plasmacytoid dendritic cells

European Journal of Immunology

Volumn 38, Issue 7, 2008, Pages 2024-2033

  Wildenberg, Manon E ^a   van Helden Meeuwsen, Cornelia G ^a   van de Merwe, Joop P ^a   Drexhage, Hemmo A ^a   Versnel, Marjan A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Plasmacytoid DC; Sj gren's syndrome; Type I interferon

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ALPHA INTERFERON INDUCIBLE PROTEIN 27; ALPHA INTERFERON INDUCIBLE PROTEIN 44; B LYMPHOCYTE ANTIGEN; BCL 2 ASSOCIATED TRANSCRIPTION FACTOR 1; BETA INTERFERON; CD40 ANTIGEN; CXCL11 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GENE PRODUCT; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERFERON; INTERFERON INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEAT 1; INTERFERON INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEAT 2; INTERFERON INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEAT 3; INTERFERON INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEAT 4; INTERFERON INDUCED TRANSMEMBRANE PROTEIN 1; INTERFERON RECEPTOR; IRON BINDING PROTEIN; LYMPHOCYTE ANTIGEN 6; MYXOVIRUS RESISTANCE PROTEIN A; PROTEINASE; STAT1 PROTEIN; SUMO PROTEIN; TRANSCRIPTION FACTOR; UBIQUITIN SPECIFIC PROTEASE 18; UNCLASSIFIED DRUG; VASCULOTROPIN C; X LINKED INHIBITOR OF APOPTOSIS;

ADULT; AGED; ARTICLE; CELL FUNCTION; CELL STRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENDRITIC CELL; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE FUNCTION; HUMAN; MALE; MICROARRAY ANALYSIS; MONOCYTE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; SJOEGREN SYNDROME; UPREGULATION; BLOOD; DNA MICROARRAY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; SALIVARY GLAND;

ADULT; AGED; ANTIGENS, CD40; DENDRITIC CELLS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INTERFERON TYPE I; MIDDLE AGED; MONOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SALIVARY GLANDS; SJOGREN'S SYNDROME; UP-REGULATION;

EID: 50549089313     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200738008     Document Type: Article

References (49)

1. Harley, J. B., Alexander, E. L., Bias, W. B., Fox, O. F., Provost, T. T., Reichlin, M., Yamagata, H. and Arnett, F. C., Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjogren's syndrome. Arthritis Rheum. 1986. 29: 196-206.
2. Watanabe, T., Tsuchida, T., Kanda, N., Mori, K., Hayashi, Y. and Tamaki, K., Anti-alpha-fodrin antibodies in Sjogren syndrome and lupus erythematosus. Arch. Dermatol. 1999. 135: 535-539.
3. Bacman, S., Perez Leiros, C., Sterin-Borda, L., Hubscher, O., Arana, R. and Borda, E., Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjogren's syndrome. Invest. Ophthalmol. Vis. Sci. 1998. 39: 151-156.
4. Kroneld, U., Halse, A. K., Jonsson, R., Bremell, T., Tarkowski, A. and Carlsten, H., Differential immunological aberrations in patients with primary and secondary Sjogren's syndrome. Scand. J. Immunol. 1997. 45: 698-705.
5. Bohnhorst, J. O., Bjorgan, M. B., Thoen, J. E., Jonsson, R., Natvig, J. B. and Thompson, K. M., Abnormal B cell differentiation in primary Sjogren's syndrome results in a depressed percentage of circulating memory B cells and elevated levels of soluble CD27 that correlate with serum IgG concentration. Clin. Immunol. 2002. 103: 79-88.
6. Theofilopoulos, A. N., Baccala, R., Beutler, B. and Kono, D. H., Type I interferons (alpha/beta) in immunity and autoimmunity. Annu. Rev. Immunol. 2005. 23: 307-336.
7. Le Bon, A. and Tough, D. F., Links between innate and adaptive immunity via type I interferon. Curr. Opin. Immunol. 2002. 14: 432-436.
8. Luft, T., Pang, K. C., Thomas, E., Hertzog, P., Hart, D. N., Trapani, J. and Cebon, J., Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 1998. 161: 1947-1953.
9. Montoya, M., Schiavoni, G., Mattei, F., Gresser, I., Belardelli, F., Borrow, P. and Tough, D. F., Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 2002. 99: 3263-3271.
10. Le Bon, A., Schiavoni, G., D'Agostino, G., Gresser, I., Belardelli, F. and Tough, D. F., Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 2001. 14: 461-470.
11. Gottenberg, J. E., Cagnard, N., Lucchesi, C., Letourneur, F., Mistou, S., Lazure, T., Jacques, S. et al., Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome. Proc. Natl. Acad. Sci. USA 2006. 103: 2770-2775.
12. Hjelmervik, T. O., Petersen, K., Jonassen, I., Jonsson, R. and Bolstad, A. I., Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren's syndrome patients from healthy control subjects. Arthritis Rheum. 2005. 52: 1534-1544.
13. Bave, U., Nordmark, G., Lovgren, T., Ronnelid, J., Cajander, S., Eloranta, M. L., Alm, G. V. and Ronnblom, L., Activation of the type I interferon system in primary Sjogren's syndrome: A possible etiopathogenic mechanism. Arthritis Rheum. 2005. 52: 1185-1195.
14. Colonna, M., Trinchieri, G. and Liu, Y. J., Plasmacytoid dendritic cells in immunity. Nat. Immunol. 2004. 5: 1219-1226.
15. Farkas, L., Beiske, K., Lund-Johansen, F., Brandtzaeg, P. and Jahnsen, F. L., Plasmacytoid dendritic cells (natural interferon-alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am. J. Pathol. 2001. 159: 237-243.
16. + (myeloid) dendritic cells in systemic lupus erythematosus. Clin. Exp. Immunol. 2005. 142: 84-91.
17. Stasiolek, M., Bayas, A., Kruse, N., Wieczarkowiecz, A., Toyka, K. V., Gold, R. and Selmaj, K., Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis. Brain 2006. 129: 1293-1305.
18. Vuckovic, S., Withers, G., Harris, M., Khalil, D., Gardiner, D., Flesch, I., Tepes, S. et al., Decreased blood dendritic cell counts in type 1 diabetic children. Clin. Immunol. 2007. 123: 281-288.
19. Der, S. D., Zhou, A., Williams, B. R. and Silverman, R. H., Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 1998. 95: 15623-15628.
20. Coelho, L. F., Magno de Freitas Almeida, G., Mennechet, F. J., Blangy, A. and Uze, G., Interferon-alpha and -beta differentially regulate osteoclastogenesis: Role of differential induction of chemokine CXCL11 expression. Proc. Natl. Acad. Sci. USA 2005. 102: 11917-11922.
21. Ronnblom, L., Eloranta, M. L. and Alm, G. V., Role of natural interferonalpha producing cells (plasmacytoid dendritic cells) in autoimmunity. Autoimmunity 2003. 36: 463-472.
22. Martinson, J. A., Tenorio, A. R., Montoya, C. J., Al-Harthi, L., Gichinga, C. N., Krieg, A. M., Baum, L. L. and Landay, A. L., Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals. Immunology 2007. 120: 526-535.
23. Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J. and Pascual, V., Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 2003. 197: 711-723.
24. Baechler, E. C., Batliwalla, F.M., Karypis, G., Gaffney, P.M., Ortmann,W. A., Espe, K. J., Shark, K. B. et al., Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. USA 2003. 100: 2610-2615.
25. Kirou, K. A., Lee, C., George, S., Louca, K., Papagiannis, I. G., Peterson, M. G., Ly, N. et al., Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. Arthritis Rheum. 2004. 50: 3958-3967.
26. Walsh, R. J., Kong, S. W., Yao, Y., Jallal, B., Kiener, P. A., Pinkus, J. L., Beggs, A. H. et al., Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis. Arthritis Rheum. 2007. 56: 3784-3792.
27. Ytterberg, S. R. and Schnitzer, T. J., Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum. 1982. 25: 401-406.
28. Dall'era, M. C., Cardarelli, P. M., Preston, B. T., Witte, A. and Davis, J. C., Jr., Type I interferon correlates with serological and clinical manifestations of SLE. Ann. Rheum. Dis. 2005. 64: 1692-1697.
29. Lovgren, T., Eloranta, M. L., Kastner, B., Wahren-Herlenius, M., Alm, G. V. and Ronnblom, L., Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjogren's syndrome autoantigen-associated RNA. Arthritis Rheum. 2006. 54: 1917-1927.
30. Diebold, S. S., Montoya,M., Unger, H., Alexopoulou, L., Roy, P., Haswell, L. E., Al-Shamkhani, A. et al., Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 2003. 424: 324-328.
31. Andoniou, C. E., van Dommelen, S. L., Voigt, V., Andrews, D. M., Brizard, G., Asselin-Paturel, C., Delale, T. et al., Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat. Immunol. 2005. 6: 1011-1019.
32. Gabriele, L., Borghi, P., Rozera, C., Sestili, P., Andreotti, M., Guarini, A., Montefusco, E. et al., IFN-alpha promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatment. Blood 2004. 103: 980-987.
33. + monocytes and the presence of activated dendritic cells in salivary glands in primary Sjogren's syndrome. Ann. Rheum. Dis. 2008. DOI 10.1136/ ard2008.087874
34. Litinskiy,M. B., Nardelli, B., Hilbert, D. M., He, B., Schaffer, A., Casali, P. and Cerutti, A., DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 2002. 3: 822-829.
35. Groom, J., Kalled, S. L., Cutler, A. H., Olson, C., Woodcock, S. A., Schneider, P., Tschopp, J. et al., Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J. Clin. Invest. 2002. 109: 59-68.
36. Mariette, X., Roux, S., Zhang, J., Bengoufa, D., Lavie, F., Zhou, T. and Kimberly, R., The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome. Ann. Rheum. Dis. 2003. 62: 168-171.
37. Jonsson, M. V., Szodoray, P., Jellestad, S., Jonsson, R. and Skarstein, K., Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjogren's syndrome. J. Clin. Immunol. 2005. 25: 189-201.
38. Pers, J. O., Daridon, C., Devauchelle, V., Jousse, S., Saraux, A., Jamin, C. and Youinou, P., BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann. N. Y. Acad. Sci. 2005. 1050: 34-39.
39. Vitali, C., Palombi, G., Baldini, C., Benucci, M., Bombardieri, S., Covelli, M., Del Papa, N. et al., Sjogren's syndrome disease damage index and disease activity index: Scoring systems for the assessment of disease damage and disease activity in Sjogren's syndrome, derived from an analysis of a cohort of Italian patients. Arthritis Rheum. 2007. 56: 2223-2231.
40. Gota, C. and Calabrese, L., Induction of clinical autoimmune disease by therapeutic interferon-alpha. Autoimmunity 2003. 36: 511-518.
41. Mariette, X., Ravaud, P., Steinfeld, S., Baron, G., Goetz, J., Hachulla, E., Combe, B. et al., Inefficacy of infliximab in primary Sjogren's syndrome: Results of the randomized, controlled trial of remicade in primary Sjogren's syndrome (TRIPSS). Arthritis Rheum. 2004. 50: 1270-1276.
42. Palucka, A. K., Blanck, J. P., Bennett, L., Pascual, V. and Banchereau, J., Cross-regulation of TNF and IFN-alpha in autoimmune diseases. Proc. Natl. Acad. Sci. USA 2005. 102: 3372-3377.
43. Vitali, C., Bombardieri, S., Jonsson, R., Moutsopoulos, H. M., Alexander, E. L., Carsons, S. E., Daniels, T. E. et al., Classification criteria for Sjogren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 2002. 61: 554-558.
44. Dik, W. A., Pike-Overzet, K., Weerkamp, F., de Ridder, D., de Haas, E. F., Baert, M. R., van der Spek, P. et al., New insights on human T cell development by quantitative Tcell receptor gene rearrangement studies and gene expression profiling. J. Exp. Med. 2005. 201: 1715-1723.
45. Irizarry, R. A., Hobbs, B., Collin, F., Beazer-Barclay, Y. D., Antonellis, K. J., Scherf, U. and Speed, T. P., Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003. 4: 249-264.
46. Bolstad, B. M., Irizarry, R. A., Astrand, M. and Speed, T. P., A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003. 19: 185-193.
47. de Ridder, D., Staal, F. J., van Dongen, J. J. and Reinders, M. J., Maximum significance clustering of oligonucleotide microarrays. Bioinformatics 2006. 22: 326-331.
48. Ge, U., Dudoit, S. and Speed, T. P., Resampling-based multiple testing for microarray analysis. Test 2003. 12: 1-77.
49. Beillard, E., Pallisgaard, N., van der Velden, V. H., Bi,W., Dee, R., van der Schoot, E., Delabesse, E. et al., Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'realtime' quantitative reverse-transcriptase polymerase chain reaction (RQPCR) - a Europe against cancer program. Leukemia 2003. 17: 2474-2486.